Palantir stock drops 5% after Fed pause, with Feb. 2 earnings in focus

Palantir stock drops 5% after Fed pause, with Feb. 2 earnings in focus

New York, Jan 28, 2026, 18:19 EST — After-hours

  • Palantir shares dropped roughly 5% on Wednesday, closing near $157.35
  • Investors are bracing for Palantir’s quarterly earnings, due Feb. 2 after markets close
  • Rates remained steady, maintaining pressure on richly valued growth stocks

Shares of Palantir Technologies (PLTR.O) dropped 5.1% to $157.35 in after-hours trading Wednesday, following an intraday range of $156.59 to $166.03.

The pullback comes as Palantir’s earnings countdown ticks closer. The company plans to release its fourth-quarter and full-year 2025 results on Feb. 2 after U.S. markets close, with a webcast scheduled for 5 p.m. ET. 1

Rate math continued to weigh on markets. On Wednesday, the Federal Reserve kept its target range for the federal funds rate steady at 3-1/2% to 3-3/4%, noting that inflation remains “still elevated.” 2

U.S. stocks ended nearly flat following the announcement, with traders swiftly turning their focus to major tech earnings and capex strategies driving the wider “AI trade.” “No matter if you were bullish or bearish before the press conference, you pretty much ended up feeling the same,” said Michael James, equity sales trader at Rosenblatt Securities. 3

Palantir’s next trigger won’t hinge on interest rates but on whether its AI pitch continues turning into deals as eagerly as investors expect. CEO Alex Karp has emphasized “the transformational impact of using AIP to compound AI leverage” and pointed to the company’s “Rule of 40” metric — which combines revenue growth and profit margin to measure software health. The firm has previously forecasted fourth-quarter revenue between $1.327 billion and $1.331 billion. 4

Traders are eyeing potential shifts in 2026 guidance, with a focus on U.S. commercial growth and the extent to which that momentum relies on Palantir’s AI Platform, or AIP, which enables clients to operate AI models on their data.

Margins are key. Palantir has focused on profitability and cash flow to offset concerns about its valuation. Investors, however, tend to react negatively whenever spending appears to be rising faster than revenue.

There’s a clear “but.” When a stock’s already priced for rapid growth, missing on guidance can trigger a steep drop. Even a strong quarter might not protect shares if management signals caution on deal timing or spending plans.

Heading into Thursday’s open, investors are watching for any ripple effects from the initial batch of megacap tech earnings. Changes in AI spending strategies have the power to quickly sway sentiment throughout the sector.

Palantir’s earnings for Feb. 2 will drop after the close, followed by a 5 p.m. ET webcast. This report could shape the stock’s momentum heading into February.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Carvana stock drops 14% after Gotham short report; CVNA heads into an earnings test
Previous Story

Carvana stock drops 14% after Gotham short report; CVNA heads into an earnings test

Oracle stock dips after TikTok outage explanation as traders size up Fed and what’s next
Next Story

Oracle stock dips after TikTok outage explanation as traders size up Fed and what’s next

Go toTop